Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide Derivatives J Ma, D Veeragoni, H Ghosh, N Mutter, G Barbosa, L Webster, R Schobert, ... Biomedicines 12 (7), 1621, 2024 | | 2024 |
Mechanistic Insights Behind the Self-Assembly of Human Insulin under the Influence of Surface-Engineered Gold Nanoparticles Z Flint, H Grannemann, K Baffour, N Koti, E Taylor, E Grier, C Sutton, ... ACS Chemical Neuroscience, 2024 | 1 | 2024 |
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer D Standing, P Dandawate, S Gunewardena, O Covarrubias-Zambrano, ... Cell Death & Disease 15 (5), 362, 2024 | | 2024 |
Tu1419 INTERRUPTING NEURAL-TUMOR SIGNALING LOOP BY TARGETING HISTAMINE RECEPTOR-1 IN PANCREATIC DUCTAL ADENOCARCINOMA H Ghosh, D Veeragoni, S Bhattacharyya, A Hamza, A Kasi, M VanSaun, ... Gastroenterology 166 (5), S-1333, 2024 | | 2024 |
SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1 AA Olou, J Ambrose, JL Jack, MK Walsh, MT Ruckert, AE Eades, BA Bye, ... Journal of Cell Communication and Signaling 17 (3), 575-590, 2023 | 4 | 2023 |
Fluorinated and N-Acryloyl-Modified 3,5-Di[(E)-benzylidene]piperidin-4-one Curcuminoids for the Treatment of Pancreatic Carcinoma H Ghosh, S Bhattacharyya, R Schobert, P Dandawate, B Biersack Pharmaceutics 15 (7), 1921, 2023 | 3 | 2023 |
Phase 1B/2A safety, pharmacokinetics and pharmacodynamics study of fosciclopirox alone and in combination with cytarabine in patients with relapsed/refractory acute myeloid … TL Lin, R Wood, T Ham, T Sullivan, P Dandawate, S Anant, ... Journal of Clinical Oncology 41 (16_suppl), TPS7078-TPS7078, 2023 | | 2023 |
566 PROLACTIN SIGNALING INDUCES GLUTAMINE METABOLISM IN PANCREATIC CANCER D Standing, P Dandawate, MA Kuehn, S Gunewardena, S Anant Gastroenterology 164 (6), S-101, 2023 | | 2023 |
Su1409 PROCHLORPERAZINE INHIBITS MAST CELL-TUMOR CELL COMMUNICATION BY TARGETING HISTAMINE RECEPTOR 1 TO REGULATE HISTONE LYSINE DEMETHYLASE 3A ACTIVITY IN PDAC H Ghosh, K Jain, S Bhattacharyya, A Kasi, A Hamza, S Weir, M VanSaun, ... Gastroenterology 164 (6), S-601, 2023 | | 2023 |
Targeting acid ceramidase-1 to inhibit sphingolipid metabolism and tumor growth in pancreatic ductal carcinoma KG Jain, H Ghosh, S Bhattacharyya, A Kasi, A Hamza, SJ Weir, ... Cancer Research 83 (7_Supplement), 1585-1585, 2023 | | 2023 |
IRAK1 is a critical mediator of hyaluronic acid induced stemness D Standing, P Dandawate, J Johnson, S Gunewardena, MT Pritchard, ... Cancer Research 83 (7_Supplement), 5020-5020, 2023 | | 2023 |
Anticancer activity of novel difluorinated curcumin analog and its inclusion complex with 2-hydroxypropyl-β-cyclodextrin against pancreatic cancer S Bhattacharyya, H Ghosh, O Covarrubias-Zambrano, K Jain, KV Swamy, ... International Journal of Molecular Sciences 24 (7), 6336, 2023 | 9 | 2023 |
New 4, 5-Diarylimidazol-2-ylidene–iodidogold (I) Complexes with High Activity against Esophageal Adenocarcinoma Cells SW Schleser, H Ghosh, G Hörner, J Seib, S Bhattacharyya, B Weber, ... International Journal of Molecular Sciences 24 (6), 5738, 2023 | 4 | 2023 |
Doublecortin‐like kinase 1 is a therapeutic target in squamous cell carcinoma D Standing, L Arnold, P Dandawate, B Ottemann, V Snyder, ... Molecular carcinogenesis 62 (2), 145-159, 2023 | 6 | 2023 |
Prolactin receptor signaling: A novel target for cancer treatment-Exploring anti-PRLR signaling strategies D Standing, P Dandawate, S Anant Frontiers in Endocrinology 13, 1112987, 2023 | 15 | 2023 |
Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (p-Cymene)dichloridoruthenium(II) Complexes N Oberhuber, H Ghosh, B Nitzsche, P Dandawate, M Höpfner, R Schobert, ... International Journal of Molecular Sciences 24 (1), 854, 2023 | 8 | 2023 |
IRAK1 is a critical mediator of low molecular weight hyaluronic acid-induced stemness in high-grade serous ovarian cancer D Standing, P Dandawate, S Gunewardena, O Covarrubias-Zambrano, ... bioRxiv, 2023.09. 25.559366, 2023 | | 2023 |
Role of bitter taste receptor in colon cancer K Jain, S Bhattacharyya, A Sayed, D Standing, K Benich, S Umar, S Anant, ... Cancer Research 82 (12_Supplement), 1529-1529, 2022 | | 2022 |
IRAK1: A novel TOLLway to target ovarian cancer D Standing, S Gunewardena, AA Sayed, MT Pritchard, HB Pathak, ... Cancer Research 82 (12_Supplement), 5306-5306, 2022 | | 2022 |
Determining the expression of RNA binding protein Rbm3 in tumor cells and immune cells in the tumor microenvironment in prostate cancer AAA Sayed, D Standing, P Dandawate, S Umar, R Jensen, R Parikh, ... Cancer Research 82 (12_Supplement), 2558-2558, 2022 | | 2022 |